Abbott Laboratories

Historical 13F Holders

Symbol
ABT
CUSIP
002824100
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 002824100 since 12/18/2024, newest first.

Filer % of Class Filed
Vanguard Capital Management LLC 13G 7.5% 4/29/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 12 0% 3/26/2026
Event 3/13/2026
Vanguard Group Inc 13G/A Amendment 11 10.1% 12/3/2025
Event 11/28/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 418 22.0 M $2.16 B
2026 Q2 3,098 1.63 B $128 B
2026 Q1 3,231 1.38 B $142 B
2025 Q4 3,398 1.45 B $177 B
2025 Q3 3,308 1.39 B $186 B
2025 Q2 3,310 1.39 B $307 B
2025 Q1 3,293 1.38 B $182 B
2024 Q4 3,198 1.36 B $154 B
2024 Q3 3,022 1.35 B $154 B
2024 Q2 2,998 1.37 B $143 B
2024 Q1 3,035 1.41 B $160 B
2023 Q4 3,020 1.37 B $151 B
2023 Q3 2,801 1.30 B $126 B
2023 Q2 2,846 1.31 B $143 B
2023 Q1 2,810 1.32 B $133 B
2022 Q4 2,869 1.38 B $180 B
2022 Q3 2,724 1.31 B $127 B
2022 Q2 2,786 1.30 B $141 B
2022 Q1 2,853 1.30 B $154 B
2021 Q4 2,903 1.31 B $184 B
2021 Q3 2,624 1.31 B $154 B
2021 Q2 2,609 1.31 B $152 B
2021 Q1 2,615 1.33 B $159 B
2020 Q4 2,581 1.32 B $146 B
2020 Q3 2,406 1.31 B $143 B
2020 Q2 2,336 1.32 B $120 B
2020 Q1 2,232 1.33 B $105 B
2019 Q4 2,281 1.35 B $118 B
2019 Q3 2,117 1.33 B $111 B
2019 Q2 2,111 1.35 B $114 B
2019 Q1 2,090 1.32 B $105 B
2018 Q4 2,054 1.35 B $97.5 B
2018 Q3 1,958 1.34 B $98.2 B
2018 Q2 1,884 1.30 B $79.0 B
2018 Q1 1,882 1.29 B $77.5 B
2017 Q4 1,830 1.27 B $72.4 B
2017 Q3 1,682 1.27 B $68.0 B
2017 Q2 1,655 1.26 B $61.4 B
2017 Q1 1,684 1.26 B $56.0 B
2016 Q4 1,606 1.12 B $42.9 B
2016 Q3 1,576 1.09 B $46.3 B
2016 Q2 1,552 1.09 B $43.5 B
2016 Q1 1,526 1.04 B $42.8 B
2015 Q4 1,577 1.04 B $47.0 B
2015 Q3 1,524 1.04 B $41.9 B
2015 Q2 1,555 1.04 B $50.9 B
2015 Q1 1,531 1.03 B $48.3 B
2014 Q4 1,565 1.06 B $48.2 B
2014 Q3 1,474 1.04 B $43.5 B
2014 Q2 1,453 1.07 B $44.3 B
2014 Q1 1,439 1.03 B $39.8 B